Background: Cholecystectomy is usually carried out for benign indications. Most perform routine histopathologic examination to detect incidental gallbladder cancer (GBC).
Introduction
Cholecystectomy (open or laparoscopic) is one of the most common surgical operations, with approximately 8000, 65 000, and 460 000 operations performed annually in Finland, UK, and USA, respectively. [1] [2] [3] Cholecystectomy is usually performed due to symptomatic or complicated cholelithiasis, and rarely due to a suspicion of neoplasm. Occasionally, surgeons encounter incidental gallbladder cancer (GBC) after routine cholecystectomy for a non-neoplastic indication. Therefore, in most centers, the excised gallbladder is routinely sent for a histopathological examination (HPE). [4] [5] [6] [7] While GBC is relatively common in Asian countries, it is a rare malignancy in Western populations. 5, 6, [8] [9] [10] [11] [12] [13] The only possibility for curative treatment of GBC is early diagnosis and radical surgery. 9, 14 According to current guidelines, cholecystectomy is sufficient for stage T1aN0 cancer. 15 However, for tumors beyond this stage, radical cholecystectomy with en bloc resection of adjacent liver parenchyma and regional lymphadenectomy is advised. 15 Overall survival remains exceptionally poor (5.1-9.5 months) in patients with unresectable GBC, but radical surgery extends the median survival to 35-53 months. 11, 16, 17 Several retrospective studies have shown a survival benefit for resection with lymphadenectomy after incidentally detected GBC, [17] [18] [19] [20] and such an approach is recommended for T1b-T3 tumors. 15 Survival after incidental GBC does not appear to rely on whether liver resection is carried out in the same operation or during reoperation at a later stage. 16, 17 Furthermore, incidental GBC has a better prognosis than symptomatic GBC. 14, 17 For these reasons, routine HPE has been recommended to detect incidental GBC. 15 However, even if a reoperation and resection is recommended after identification of incidental GBC, it is not clear whether routine HPE of all excised gallbladders offers a diagnostic advantage over macroscopic examination and selective HPE for those with macroscopic abnormalities. The aim of this study, therefore, was to assess the rate of incidental GBC in macroscopically normal gallbladders.
Material and methods
This was a retrospective cohort study including patients treated in 4 hospitals in the Helsinki Metropolitan Area (Surgical Hospital, Meilahti Hospital, Jorvi Hospital, and Peijas Hospital), all of which are administratively part of the Helsinki University Hospital, with a total patient catchment area of approximately 1 000 000 individuals. Patients were identified from an electronic operative registry using the procedure codes for open and laparoscopic cholecystectomy (JKA20 and JKA21).
The aim was to collect at least 2000 patients undergoing cholecystectomy to detect at least 10 patients with incidental gallbladder cancer, assuming an incidence of 0.5%. Based on initial calculations, a 1.5 year time period was chosen, which was then extended by 2 months to obtain the target study population. Furthermore, the period was chosen such that a sufficient follow-up of at least 3 years from cholecystectomy would be available. The final index cholecystectomy period was from November 2010 to May 2012, and data were collected during 2016. Patients who had undergone open or laparoscopic cholecystectomy as their primary operation (i.e. not as a secondary operation performed concomitantly with an alternative primary operation) during the chosen time period were included. Exclusion criteria were: 1) clinical or radiological suspicion of gallbladder neoplasia prior to the operation, and 2) any active malignancy or malignancy that had been in remission less than 5 years.
Data were collected from electronic patient records in a preformatted SPSS sheet (SPSS Statistics ver. 22, IBM, Armonk, NY). Basic demographics, operative details, macro-and microscopic findings, and follow-up were extracted. The indication for surgery was defined as the main reason for cholecystectomy at the time of the operation, although other indications, such as previous episodes of cholecystitis or pancreatitis, might have been present. Cholecystectomies performed during an emergency admission were classified as emergent, whilst others were classified as elective procedures.
Any macroscopic description of thickening, tumor, polyp, or necrosis in the operation record was interpreted as a pathology of the gallbladder. The routine method to evaluate the resected gallbladders in these hospitals is to open the gallbladder after resection, inspect the mucosa, and mark the contents of the gallbladder (stones, sludge, etc). The end of follow-up was defined as the last verified contact or visit based on the electronic patient records. Patients whose gallbladder was not sent for HPE were crosschecked using the Finnish Cancer Registry (FCR) in 2015 to verify that no malignancies were missed in these patients. FCR covers the whole Finland with 96% completeness regarding solid tumors. 21 This study was approved by the institutional review board of Helsinki University Hospital and the National Institute for Health and Welfare.
Results

Patients
Of the 2317 patients identified, 2034 patients met the inclusion and exclusion criteria and were included in the study (Fig. 1 ). The basic patient and operative characteristics are shown in Table 1 .
Micro-and macroscopic findings
The macroscopic description was normal in 70.0% and 60.8% of gallbladders, as assessed by the surgeon and pathologist, respectively ( Table 2 ). Histopathological analysis was performed on 94% of gallbladders (n = 1916). Of the 118 gallbladders not sent for HPE, 112 were reported as macroscopically normal, while six exhibited a thickened or necrotic wall. Ten GBC were found by HPE. The macroscopic appearance of these gallbladders, as described by the surgeon, was as follows: local hardness (n = 1), thickened wall (n = 5), acute cholecystitis (n = 1), and neoplastic (n = 3). Thus, the rate of GBC in patients without signs of malignancy in preoperative imaging was 0.5% (n = 10). No GBC was found in patients with a macroscopically normal gallbladder. Of note, one other patient derived diagnostic benefit from HPE when a suspicion of primary sclerosing cholangitis was established on the basis of histopathological findings. In this patient, the gallbladder wall was also thickened. Patients whose gallbladders were not sent for HPE were crosschecked with the Finnish Cancer Registry for instances of missed GBC; however, none were identified.
Patients with incidental GBC
The male/female ratio among patients with GBC was similar to patients undergoing cholecystectomy (two-thirds female) ( Table 3 ). The median age was 74 years (range 49-84 years), with only one patient younger than 50 years of age. Six of these patients (60%) underwent elective cholecystectomy, and none had a history of acute cholecystitis. Four patients underwent emergency cholecystectomy due to acute cholecystitis. Of note, nine patients had been evaluated with US, one with CT, and three with MRI prior to the operation without suspicion of malignancy. Five patients underwent further liver resection to obtain wider margins. Two patients were deemed inoperable at exploratory laparotomy, and three patients were found to have metastatic disease in their preoperative CT scans ( Table 4 ).
Seven of the 10 patients died of disseminated disease during the follow-up, with an overall median survival of 14 months (IQR 12.1-28.4). Patients with metastatic disease who did not undergo liver resection (n = 5) had a similar survival to that observed for all seven patients dying during the study period (14 months, IQR 11-38.5). However, the median survival of patients who underwent liver resection could not be determined, as three of the five patients were alive and disease-free after a median of 48 months follow-up (36-56 months).
Discussion
In the present study, GBC was found in 10 out of 2034 patients (0.5%) undergoing cholecystectomy for a benign indication without any suspicion of malignancy prior to surgery. No GBC was found in gallbladders deemed normal upon macroscopic examination by the surgeon, and all cases of GBC had some form of abnormal macroscopic appearance, albeit not necessary a tumor. These findings suggest that selective HPE after cholecystectomy is sufficient. However, it must be stressed that the surgeon should carefully examine the specimen, with only macroscopically normal gallbladders qualifying for omission from routine HPE.
The necessity of HPE after cholecystectomy has been assessed in several studies before, with conflicting evidence. Some studies have claimed that all GBC can be detected macroscopically, and routine histopathology is not needed. 7, 22 Others have suggested that a thickened wall is always present in cases of GBC. 11 The rate of incidental GBC in these reports varied between 0.2% and 0.4%, which is similar to the present study. However, a number of reports advocate for routine HPE of all cholecystectomy specimens. In such studies, the rates of incidental GBC were similar to that observed in this study, but these studies did not consider the role of macroscopic examination and the possibility of selective HPE. 23, 24 Furthermore, recent studies have found that all GBC is associated with some form of macroscopic abnormality, with no GBC found in patients with a macroscopically normal gallbladder. 4, 5, 25 Our results mirror such findings, with all cases in this study exhibiting a thickened wall, macroscopically neoplastic lesion, or, in 1 case, acute inflammatory findings. Importantly, previous work has suggested that a policy shift towards selective HPE would save 1.3 million EUR a year in the Netherlands alone. 4 The cost of gallbladder HPE in our hospital district is approximately 80 EUR, meaning that selective HPE for macroscopically abnormal cholecystectomy specimens would save roughly 0.5 million EUR per year in Finland (assuming 70% exhibit a grossly normal appearance and an annual rate of 8000 cholecystectomies).
Previous studies have reported macroscopic abnormality rates of between 13% and 43% in gallbladders removed for benign indications, 4,25 similar to that observed in this study (30%). Although the rate of GBC among macroscopically abnormal gallbladders is minimal (1-3%), it would appear that routine HPE in these cases is justified. If GBC is diagnosed symptomatically following previous cholecystectomy without routine HPE, the overall resectability rate is 8%, compared to 70% if GBC is detected early based on HPE. 26 This is confirmed by our findings of a 50% resectability rate for incidental GBC, and the fact that 3 of these patients were disease-free at a median 48 months of follow-up. Notably, these patients had T2N0 GBC without residual tumor found during reoperation, while patients with lymph node metastases exhibited poor survival. Although 6 macroscopically abnormal gallbladders were not sent for HPE and exhibited no late GBC, we do not recommend such a policy.
Several limitations should be noted with respect to this study. First, this was a retrospective study, which may limit the accuracy of the data due to an inability to prospectively control potential confounders, such as a lack of formal standardization for macroscopic examination of the gallbladder. Second, despite a relatively high number of patients undergoing cholecystectomy, the incidence of GBC was very low, limiting the power of the study.
Many traditions remain in modern medicine. Routine HPE for all cholecystectomy specimens is one such tradition. This study, along with previous studies, suggests that selective HPE may be safe, financially advantageous, and effective in reducing the load on pathology departments in an era when healthcare resources are already heavily strained. Based on our study, and similar results from others, we have changed our policy towards selective HPE in macroscopically abnormal gallbladders only. Follow-up, years 2.9 (0.1-4.06) a Prophylactic cholecystectomy performed prior to transplantation. 
